PhuaJWengLLingL, et al. Intensive care management of coronavirus disease 2019 (COVID-19): Challenges and recommendations. Lancet Respir Med. Epub ahead of print 6 April 2020. DOI:10.1016/S2213-2600(20)30161-2.
2.
CheungOYChanJWMNgCK, et al.
The spectrum of pathological changes in severe acute respiratory syndrome (SARS). Histopathology2004;
45: 119–124.
3.
HuiDSWongKTKoFW, et al.
The 1-year impact of severe acute respiratory syndrome on pulmonary function, exercise capacity, and quality of life in a cohort of survivors. Chest2005;
128: 2247–2261.
4.
NgaiJCKoFWNgSS, et al.
The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status. Respirology2010;
15: 543–550.
5.
ZhangPLiJLiuH, et al.
Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: A 15-year follow-up from a prospective cohort study. Bone Res2020;
8: 8.
6.
ChangYCYuCJChangSC, et al.
Pulmonary sequelae in convalescent patients after severe acute respiratory syndrome: evaluation with thin-section CT. Radiology2005;
236: 1067–1075.
7.
WuXDongDMaD.Thin-section computed tomography manifestations during convalescence and long-term follow-up of patients with severe acute respiratory syndrome (SARS). Med Sci. Monit2016;
22: 2793–2799.
8.
ZhangHZhouPWeiY, et al. Histothologic changes and SARS-CoV-2 immunostaining in the lung of a patient with COVID-19. Ann Intern Med. Epub ahead of print 12 March 2020. DOI:10.7326/M20-0533.
9.
Cabrera-BenitezNELaffeyJGParottoM, et al.
Mechanical ventilation-associated lung fibrosis in acute respiratory distress syndrome: A significant contributor to poor outcome. Anesthesiology2014;
121: 189–198.
10.
ZhaoXNichollsJMChenYG, et al.
Severe acute respiratory syndrome-associated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor-beta signaling. J Biol Chem2008;
283: 3272–3280.
11.
Tilocca B, Soggiu A, Sanguinetti M, et al. Comparative computational analysis of SARS-CoV-2 nucleocapsid protein epitopes in taxonomically related coronaviruses. Microb Infect. Epub ahead of print 14 April 2020. DOI:10.1016/j.micinf.2020.04.002.
12.
ZuoWZhaoXChenYG.SARS coronavirus and lung fibrosis. In: LalS (ed.) Molecular biology of the SARS-coronavirus.
Berlin and Heidelberg:
Springer, 2010, pp.247–258.
13.
BarisonAAimoACastiglioneV, et al. Cardiovascular disease and COVID-19: les liaisons dangereuses. Eur J Prev Cardiol. 2020; 27: 1017–1025.
14.
VillarJConfalonieriMPastoresS, et al.
Rationale for prolonged corticosteroid treatment in the acute respiratory distress syndrome caused by coronavirus disease2019. Crit Care Explor 2020;2: e0111.
15.
BrojakowskaANarulaJShimonyR, et al. Clinical implications of SARS-Cov2 interaction with renin angiotensin system. J Am Coll Cardiol. Epub ahead of print 15 April 2020. DOI: 10.1016/j.jacc.2020.04.028.
